CIABATTONI, Giovanni
 Distribuzione geografica
Continente #
NA - Nord America 5.970
AS - Asia 4.200
EU - Europa 4.086
SA - Sud America 392
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 4
Totale 14.712
Nazione #
US - Stati Uniti d'America 5.876
SG - Singapore 1.648
CN - Cina 1.201
UA - Ucraina 813
TR - Turchia 645
IE - Irlanda 605
GB - Regno Unito 568
SE - Svezia 506
RU - Federazione Russa 498
FR - Francia 343
BR - Brasile 327
DE - Germania 316
VN - Vietnam 285
FI - Finlandia 200
IN - India 191
IT - Italia 142
CA - Canada 44
MX - Messico 35
HK - Hong Kong 32
BD - Bangladesh 28
AR - Argentina 26
PL - Polonia 22
KR - Corea 21
ZA - Sudafrica 21
IQ - Iraq 19
CZ - Repubblica Ceca 15
ID - Indonesia 15
PK - Pakistan 15
JP - Giappone 14
ES - Italia 13
SA - Arabia Saudita 11
EC - Ecuador 10
NL - Olanda 10
EU - Europa 9
IL - Israele 9
AT - Austria 8
PH - Filippine 8
UZ - Uzbekistan 8
IR - Iran 7
VE - Venezuela 7
CO - Colombia 6
JO - Giordania 6
LT - Lituania 6
MA - Marocco 6
DZ - Algeria 5
EG - Egitto 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
QA - Qatar 4
TW - Taiwan 4
UY - Uruguay 4
AL - Albania 3
AU - Australia 3
BE - Belgio 3
BO - Bolivia 3
HN - Honduras 3
KG - Kirghizistan 3
NI - Nicaragua 3
RO - Romania 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
BB - Barbados 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
CL - Cile 2
CR - Costa Rica 2
KZ - Kazakistan 2
MY - Malesia 2
PA - Panama 2
PE - Perù 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BY - Bielorussia 1
CH - Svizzera 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MD - Moldavia 1
MK - Macedonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
Totale 14.712
Città #
Singapore 1.241
Jacksonville 857
Chandler 740
San Jose 610
Dublin 602
Southend 454
Ashburn 347
Princeton 314
Beijing 312
Izmir 311
Dallas 237
Nanjing 202
Wilmington 184
Santa Clara 176
Los Angeles 155
Cambridge 143
Dearborn 132
Tongling 107
Ho Chi Minh City 94
Munich 83
Buffalo 79
New York 77
The Dalles 76
Nanchang 74
Woodbridge 68
Moscow 66
Hanoi 61
Ann Arbor 60
Boardman 58
Shenyang 45
Council Bluffs 41
Altamura 40
São Paulo 35
Hebei 34
Kunming 34
Tianjin 34
Grevenbroich 33
Washington 33
Helsinki 30
Changsha 28
Jiaxing 28
Turku 28
Houston 27
Hong Kong 26
Norwalk 24
Brooklyn 23
Denver 22
Chennai 20
Seoul 20
Haiphong 18
Montreal 18
Hangzhou 17
Orem 17
Redondo Beach 17
Warsaw 17
Da Nang 16
Hefei 16
Atlanta 15
Augusta 15
Orange 15
Chieti 14
Falls Church 14
Poplar 14
Tokyo 14
Frankfurt am Main 13
Jinan 13
Johannesburg 13
San Mateo 13
Boston 12
Seattle 12
Chicago 11
Toronto 11
Baghdad 10
Brno 10
Mexico City 10
Phoenix 9
Stockholm 9
Belo Horizonte 8
Changchun 8
Lanzhou 8
Rio de Janeiro 8
Zhengzhou 8
Auburn Hills 7
Brasília 7
Leawood 7
Mumbai 7
San Francisco 7
Amsterdam 6
Ankara 6
Biên Hòa 6
Guayaquil 6
London 6
Manchester 6
Querétaro 6
Roubaix 6
Shanghai 6
Tashkent 6
Amman 5
Bắc Ninh 5
Can Tho 5
Totale 9.058
Nome #
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 179
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Amylin inhibits hypothalamic dopamine release. 155
Determinants of platelet activation in hypertensives with microalbuminuria. 152
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 152
A Polymorphism in the Cyclooxygenase 2 Gene as an Inherited Protective Factor Against Myocardial Infarction and Stroke 151
Soluble CD40L in Mediterranean Spotted Fever: relation to oxidative stress and platelet activation 150
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 150
Aging increases amyloid beta-peptide-induced 8-iso-prostaglandin F2alpha release from rat brain. 148
Chromatin derived acid peptides inhibit dopamine and norepinephrine release in the hypothalamus. 146
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 143
Effect of CART peptide-(55-102), leptin and orexin-B on hypothalamicserotonin release. 142
Helicobacter pylori infection causes persistent platelet activation in vivo through enhanced lipid peroxidation 142
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 140
Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during neutrophil granulocytic differentiation and contributes to maturation. 139
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 138
Anterior pituitary cell production of 8-iso-prostaglandin F2alpha. 135
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 135
8-Isoprostane in exhaled breath condensate (EBC)and excercise-induced bronchoconstriction in asthmatic children and adolescents 134
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 132
Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins. 132
Abnormal pH-sensing of platelet Na+/H+ exchanger in patients with cardiac syndrome X 131
Decreased plasma soluble rage in patients with hypercholesterolemia: effects of statins. 131
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. 129
Insulin resistance as a determinant of platelet activation in obese women. 129
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 126
Circulating MRP 8/14 is Associated with Thromboxane Dependent Platelet Activation in NSTEMI Patients: Effect of Aspirin Treatment 126
Effects of atorvastatin and rosuvastatin on thromboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 126
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 124
Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress. 124
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 121
Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus. 121
Determinants of platelet activation in hypertensives with microalbuminuria. 121
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 121
Problemi di metodologia per la individuazione del rischio tossicologico. Consiglio Nazionale delle Ricerche 120
Soluble RAGE in type 2 diabetes: association with oxidative stress. 119
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 119
Association between PAI-1 and Oxidative Stress in Android Obesity 119
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 119
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 118
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 116
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 116
Cyclooxygenase-2 expression is induced during human megakaryopoiesis and characterizes newly formed platelets. 115
Attivazione piastrinica e stress ossidativo in vivo nell’artrite reumatoide. 115
Acute, short-term hyperglycemia enhances shear stress-induced platelet activation in patients with type II diabetes mellitus. 114
Effects of anthracyclines on hypothalamic dopamine release. 114
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 113
Acute effects of air pollution on pulmonary function, airway inflammation, and oxidative stress in asthmatic children. 113
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 113
Determinants of platelet activation in Alzheimer's disease 113
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 111
Thromboxane-dependent CD40L release in type 2 diabetes mellitus 111
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 111
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 111
Insulin resistance as a determinant of platelet activation in obese women 110
Effects of cocaine- and amphetamine-regulated transcript peptide, leptin and orexins on hypothalamic serotonin release. 109
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 108
Tachykinin-eicosanoid crosstalk in airway inflammation 108
Anaphylaxis increases 8-iso-PGF2alpha release from guinea-pig lung in vitro 108
Measurement of 8-isoprostane in exhaled breath condensate. 107
Increased thromboxane biosynthesis in essential thrombocythemia 106
Role of Platelet Activation in Dementia 106
Increased exhaled 8-isoprostane in childhood asthma. 106
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 106
Drugs, prostaglandins, and renal function. 105
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 105
Determinants of Platelet Activation in Heart Failure. 105
Effect of gherlin and amylin on hypothalamic dopamine, norepinephrine and serotonin release. 104
Platelet activation in obese women: role of inflammation and oxidant stress. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Exhaled 8-Isoprostane as an In Vivo Biomarker of Lung Oxidative Stress in Patients with COPD and Healthy Smokers 103
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 103
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 101
Soluble CD40L in Mediterranean Spotted Fever: Relation to oxidative stress and platelet activation. 100
Platelet Activation Markers in Patients with Peripheral Arterial Disease. A Prospective Comparison of Different Platelet Function Tests 100
Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium 99
Enhanced Lipid Peroxidation and Platelet Activation as Potential Contributors to Increased Cardiovascular Risk in the “Low-HDL” Phenotype 99
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 99
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control 98
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 98
Modulation of the expression and activity of cyclooxygenases in normal and accelerated erytrhopoiesis. 97
Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide 97
Validation of leukotriene B4 measurements in exhaled breath condensate. 96
Determinants of Platelet Activation in Heart Failure. 96
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 95
Soluble CD40L as an indicator of platelet Activation in Heart Failure 95
Increased macrothrombocytopenia with distinctive platelet ultrastructural and functional features 94
Oxidative stress and platelet activation in children and adolescents with type 1 diabetes: role of interleukin-6 94
Identification of 8-iso-prostaglandin (PG) F2alfa in rat brain neuronal endings: a possible marker of membrane phospholipid peroxidation. 93
Effects of montelukast treatment and withhdrawal on fractional exhaled nitric oxide and lung function in children with asthma 93
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 92
Inherited Macrothrombocytopenia with Distinctive Platelet Ultrastructural and Functional Features 91
Signaling pathways involved in lipopolysaccharide stimulation of prostaglandin production by rat hypothalamic astroglial cells 91
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis 91
Low-density lipoprotein level reduction by the 3-hydroxy-3-methylglutaryl coenzima-A inhibitor sinvastatin is accompanied by a related reduction of F2-isoprostane formation in hypercholesterolemic subjects: no further effect of vitamin E. 91
Effects of atorvastatin and rosuvastatin on throboxane-dependent platelet activation and oxidative stress in hypercholesterolemia. 91
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 91
Enhanced lipid peroxidation and platelet activation in the early stages of type 1 diabetes mellitus. Role of Interleukin-6 and disease duration. 91
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 91
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 90
Totale 11.559
Categoria #
all - tutte 54.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021192 0 0 0 0 0 0 0 0 0 151 8 33
2021/2022598 17 7 4 118 71 9 11 43 45 11 78 184
2022/20231.930 159 197 126 222 189 447 115 134 233 19 39 50
2023/2024801 62 33 60 22 48 256 216 25 2 7 9 61
2024/20252.395 149 524 484 28 19 55 20 91 174 64 277 510
2025/20264.039 429 255 407 464 423 299 801 213 470 278 0 0
Totale 14.960